The Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Veklury, the brand name for Remdesivir, and the opportunity to increase supply beyond the 500,000 treatment courses. There are 36 signatories of the Joint Procurement Agreement participating in this joint procurement,…
Tag: Didier Raoult
EU €63M Remdesivir contract with U.S.Gilead
#COVID19 European Commission has signed a contract with the pharmaceutical company Gilead on July 28 to secure treatment doses of Veklury, the brand name for Remdesivir. The medicine Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the California biopharmaceutical company Gilead Sciences Inc. It is administered via injection into…
EUROPE DIPLOMATIC 